Medical News

RSS

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company’s New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.

25 Aug 2009

OriGene Technologies releases recombinant proteins purified from HEK293 cells

OriGene Technologies, Inc. announces the release of 5,000 purified human proteins, representing the most comprehensive offering of human cell-produced human proteins.

25 Aug 2009

Combined therapy for acute leukemia shows promising results

Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

25 Aug 2009

Study reveals safety of ConvaTec's advanced antimicrobial dressing

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced new data showing that AQUACEL(R) Ag, the company's advanced antimicrobial dressing, is safe for use in an MRI environment.

25 Aug 2009

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

Diplomat Specialty Pharmacy announced today that its Diplomat Health Services Division is partnering with CareSource in Ohio to slow the progression of Chronic Kidney Disease (CKD), improve clinical outcomes and reduce healthcare costs associated with the disease. As the number of Americans with CKD continues to rise, CareSource is focused on the early identification and treatment of their patients with the illness.

25 Aug 2009

Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009

Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.

25 Aug 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

A landmark report released today by the Lance Armstrong Foundation (LAF) estimates the total economic burden of new cancer cases at $305 billion in 2009. The findings are included in the report, "Breakaway: The Global Burden of Cancer - Challenges and Opportunities," released today in Dublin at the premiere LIVESTRONG Global Cancer Summit.

25 Aug 2009

Aging with Dignity president urges Department of Veterans Affairs to suspend use of advance care planning guide

Paul Malley, President of the national non-profit organization Aging with Dignity, today called on the Department of Veterans Affairs to immediately suspend use of its "Your Life, Your Choices" advance care planning guide dubbed "The Death Book for Veterans." Malley also praised Sen. Arlen Specter (D-PA), a member of the U.S. Senate Committee on Veterans' Affairs, who announced on "Fox News Sunday" yesterday that he would call for hearings into the matter.

25 Aug 2009

States pass laws to expand parents' ability to insure 20-somethings

Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."

25 Aug 2009

Malaysian biotechnology industry expected to grow by revenue at an average rate of 15 percent per year

Malaysia's plans for its biotechnology sector remain ambitious even with the recent global meltdown. By 2020 the government envisages this sector will employ up to 160,000 people and will contribute to 5% of Malaysia's GDP.

25 Aug 2009

A new therapy for treating gastro-oesophageal reflux in babies

20% of parents seek medical help because of the frequent regurgitation (spitting up food) of their baby and the accompanying discomfort (crying). Reputed medical journal "Archives of Disease in Childhood" of the "British Medical Journal" group recently published the results of the clinical research project that began at the end of 2006 in the Children's gastroenterology department of the Brussels University Hospital.

25 Aug 2009

Emdeon and BroMenn Healthcare System implement an interactive software application for transparent pricing of healthcare

Emdeon, a leading provider of revenue and payment cycle management solutions for the healthcare industry, and BroMenn Healthcare System, headquartered in Bloomington-Normal, Illinois, recently implemented the Emdeon Patient Responsibility Estimator(SM) solution. Emdeon Patient Responsibility Estimator is an interactive software application used by BroMenn's patient access staff to inform patients of their financial responsibility prior to care delivery.

25 Aug 2009

Unotron collaborates with GHA Technologies to supply washable data input devices

School systems throughout the nation have a strong ally in mitigating a resurgence of swine flu this fall. UNOTRON (www.unotron.com), worldwide creator of medical grade, washable computer keyboards, scroll wheel mice, and smartcard readers, announces that it is teaming up with GHA Technologies, Inc. (www.gha-associates.com) to offer Unotron’s high quality, washable data input and security devices.

25 Aug 2009

TIME examines discrimination against HIV-positive children in Vietnam

TIME examines the discriminatory efforts to keep Vietnamese children living with HIV out of the country's public schools even though, by law, "[c]hildren cannot be barred from school because they or any of their family members have HIV/AIDS."

25 Aug 2009

Mark Booth joins Orexigen Therapeutics as the Chief Commercial Officer

Orexigen((R)) Therapeutics, Inc. today announced that Mark Booth has joined the Company as Chief Commercial Officer. Mr. Booth brings over 25 years of commercial and business development experience to Orexigen. Most recently he served as President of Takeda Pharmaceuticals North America (TPNA) where he presided over the commercial, medical and scientific affairs, business development and all support functions.

25 Aug 2009

PediaVision device to detect eye disorders in autistic children

PediaVision, a company dedicated to solving the critical problem of undiagnosed vision problems affecting thousands of children, today announced a breakthrough in the use of the PediaVision Assessment Solution for autistic children.

25 Aug 2009

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

The program created to provide Medicare recipients with prescription drug benefits exceeded expectations during its first two years, extending pharmacy coverage to most seniors while reducing their overall spending on drugs, according to a new RAND Corporation study.

25 Aug 2009

Medical News

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

OriGene Technologies releases recombinant proteins purified from HEK293 cells

Combined therapy for acute leukemia shows promising results

Study reveals safety of ConvaTec's advanced antimicrobial dressing

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

Aging with Dignity president urges Department of Veterans Affairs to suspend use of advance care planning guide

States pass laws to expand parents' ability to insure 20-somethings

Malaysian biotechnology industry expected to grow by revenue at an average rate of 15 percent per year

A new therapy for treating gastro-oesophageal reflux in babies

Emdeon and BroMenn Healthcare System implement an interactive software application for transparent pricing of healthcare

Unotron collaborates with GHA Technologies to supply washable data input devices

TIME examines discrimination against HIV-positive children in Vietnam

Mark Booth joins Orexigen Therapeutics as the Chief Commercial Officer

PediaVision device to detect eye disorders in autistic children

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

Karo Bio collaborates with Wyeth for treating inflammatory diseases

Department of Veterans Affairs to simplify rules for PSTD compensation claimants

University of Southampton develops a microfluidic single-cell impedance cytometer for blood cell analysis

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News